Effect of Newly Approved Medications Sacubitril/Valsartan, Empagliflozin and Dapagliflozin on the Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Setouhi, Amr [1 ]
Taha, Asmaa [2 ]
Farrag, Hazem M. A. [1 ]
Asklany, Hany T. [1 ]
机构：
[1] Minia Univ, Dept Cardiol, Fac Med, Al Minya, Egypt
[2] Minia Univ, Dept Community, Fac Med, Al Minya, Egypt
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2023年 / 25卷
关键词：
Heart failure with reduced ejection fraction center dot Sacubitril/Valsartan ~; Dapagliflozin center dot Empagliflozin center dot Quality of Life;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect Of Empagliflozin On Major Heart Failure Outcomes, Renal Function And Quality Of Life In Patients With Heart Failure With A Reduced Ejection Fraction, With And Without Sacubitril/valsartan
    Packer, Milton
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (12) : 1109 - 1109
  • [2] Effect on the Quality of Life of Patients with Heart Failure and Reduced/Preserved Ejection Fraction Using Sacubitril/Valsartan
    Huang, Yuanrui
    Wu, Xu
    Li, Xingyu
    Liu, Zhengzhong
    Li, Yunyi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (08)
  • [3] Comparative Cost-Effectiveness of Sacubitril-Valsartan, Dapagliflozin, and Empagliflozin in Heart Failure With Reduced Ejection Fraction
    Parikh, Neil U.
    Dixit, Neal
    Ziaeian, Boback
    Fonarow, Gregg C.
    CIRCULATION, 2022, 146
  • [4] Combined treatment with sacubitril/valsartan plus dapagliflozin in patients affected by heart failure with reduced ejection fraction
    Jiang, Juan
    Gao, Jie
    Zhang, Xiuzhen
    Li, Yuanmin
    Dang, Heqin
    Liu, Yanlin
    Chen, Wenwen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [5] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [6] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [7] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [9] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [10] COST-EFFECTIVENESS OF DAPAGLIFLOZIN VERSUS SACUBITRIL/VALSARTAN FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION
    McEwan, P.
    Darlington, O.
    Bergenheim, K.
    Qin, L.
    VALUE IN HEALTH, 2020, 23 : S494 - S494
12345